CiteScore measures average citations received per document published in the serial.
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Indexed in the following public directories
Overview | |
Publisher | Elsevier |
Language | English |
Article Processing Charges | USD 2000 |
Publication Time | 10 |
Editorial Review Process | Blind peer review |
General Details | |
Language | English |
Society/Institute/Sponsor | Chinese Academy of Sciences, Shanghai Institute of Materia Medica, The National Center for Drug Screening |
Website URL | Visit website |
Publication Details | |
Plagiarism | Visit website |
Waiver Policy | Visit website |
Publication Time | 10 |
Article Processing Charges | USD 2000 |
Editorial Review Detail | |
Editorial Team | Visit website |
Review Process | Blind peer review |
Review Url | Visit website |
Information for authors | |
Author instructions | Visit website |
License type | CC BY, CC BY-NC-ND |
OA statement | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper188 articles received 2.7k citations see all
In 2024, Medicine in Drug Discovery published 25 articles.
Citescore for Medicine in Drug Discovery is 2.
Elsevier is the publisher of Medicine in Drug Discovery.